Labeling proteins with Tc-99m via hydrazinonicotinamide (HYNIC): optimization of the conjugation reaction

This publication has 8 references indexed in Scilit:

• Different behaviour of radioiodinated human recombinant interleukin-1 and its receptor antagonist in an animal model of infection
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Labeling a Hydrazino Nicotinamide-Modified Cyclic IIb/IIIa Receptor Antagonist with ^99mTc Using Aminocarboxylates as Coligands
  Bioconjugate Chemistry, 1996
• A Comparison of Cleavable and Noncleavable Hydrazinopyridine Linkers for the^99mTc Labeling of Fab‘ Monoclonal Antibody Fragments
  Bioconjugate Chemistry, 1996
• Comparative evaluation of 99Tcm-Hynic-HSA and 99Tcm-MAG3-HSA as possible blood pool agents
  Nuclear Medicine Communications, 1995
• Preparation of hydrazino-modified proteins and their use for the synthesis of technetium-99m-protein conjugates
  Bioconjugate Chemistry, 1991
• Progress in research on ligands, nuclides and techniques for labeling monoclonal antibodies
  International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
• Recent developments in the radiolabeling of antibodies with iodine, indium, and technetium
  Seminars in Nuclear Medicine, 1990
• Determination of the immunoreactive function of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess
  Journal of Immunological Methods, 1984